CRL grants $5M long-term equity award to EVP LaPlume with 5-year cliff vesting and rTSR PSUs

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Joseph W. LaPlume receives $5M total fair value: 50% RSUs (6,771 units) cliff vesting Dec 25, 2026.
50% in PSUs (5,096 target) based on 5-year relative TSR vs S&P Healthcare 500, payout 0%-200%.
Grant effective Dec 25, 2021; recognizes LaPlume's contributions and critical role in strategic growth.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.